Latest Lab Partnerships & Innovations in Benelux | Analis News

7 Articles

Clinical centrifuges × DNA / RNA (Nucleic acids) × Hematology × POCT × Parallel synthesis ×

The new Benchtop Centrifuges Sigma 3 Series

SIGMA NEW SERIES 3: All-rounder for 1.6 litres with touch control The new Sigma 3-16T and Sigma 3-17KT are benchtop centrifuges are based on the requirements of modern laboratories. Both models featur...

Benchtop centrifuges Clinical centrifuges

Continue reading

Reactor Ready Mini: A Compact Small Lab Reactor for Faster Process Development

The Radleys Reactor-Ready Mini is a compact, small jacketed reactor supporting 50 ml to 500 ml vessels with accurate temperature control, efficient stirring, dosing, and a scalable process. Reactor-Re...

Glass reactors Parallel synthesis Synthesis

Continue reading

New Exclusive Partnership with GeneMind Biosciences

Analis Expands End to End Next Generation Sequencing Capabilities for Benelux Laboratories with GeneMind Biosciences. This new exclusive partnership between Analis and GeneMind is built on a shared be...

DNA / RNA (Nucleic acids) Next Generation Sequencing (NGS)

Continue reading

Radleys NEW AVA Pad Reactor Controller

AVA Pad Reactor Controller One Box. Any Reactor. Effortless Automation. AVA Pad is a compact, subscription-free, out-of-the-box controller that brings effortless automation to any jacketed lab reactor...

Glass reactors Parallel synthesis Synthesis

Continue reading

Redifine mutation detection

Advancing molecular diagnostics through a technology that is redefining how low‑frequency mutations are being detected. Using equipment that is already readily available in most laboratories. What is ...

DNA / RNA (Nucleic acids) Flow cytometry analyzers for research Flow cytometry reagents

Continue reading

Analis Enters Strategic Partnership with PixCell Medical to Expand POCT Hematology Offering

Analis is proud to announce a new partnership with PixCell Medical , an innovator in point-of-care hematology testing. This collaboration brings the HemoScreen™ , the first FDA-cleared, IVDR CE-mark-a...

Hematology POCT

Continue reading

Analis has decided to invest in different disruptive POCT technologies

We are thrilled to announce that Analis has made a significant investment in the latest Point-of-Care Testing (POCT) technologies to support diagnostic laboratories and healthcare professionals in obt...

POCT POCT RT-PCR Molecular Diagnostics

Continue reading